-
公开(公告)号:US11963962B2
公开(公告)日:2024-04-23
申请号:US17266262
申请日:2019-08-21
Applicant: Sierra Oncology, Inc.
Inventor: Barbara Jane Klencke , Gregg David Smith , Rafe Michael Joseph Donahue
IPC: A61K31/5377 , A61K9/00 , A61P35/00
CPC classification number: A61K31/5377 , A61K9/0053 , A61P35/00
Abstract: Reanalysis of the SIMPLIFY 1 and 2 trials data indicates MMB is effective in JAKi-naïve patients and in second line therapy to RUX, providing benefits of reducing enlarged spleens, improving myelofibrosis-related symptoms, and increasing transfusion independence in patient at risk for thrombocytopenia from the underlying disease and RUX therapy. Accordingly, methods of treating myeloproliferative neoplasms (MPN) such as myelofibrosis are described. The methods can include administering a therapeutically effective amount of momelotinib or a pharmaceutically acceptable salt thereof to a subject identified as having (i) myelofibrosis and (ii) a platelet count of less than 150×109/L. Also described are methods including administering to a subject with myelofibrosis a therapeutically effective stable dose of momelotinib or a pharmaceutically acceptable salt thereof, for a period of a plurality of weeks, where the subject is assessed as maintaining a platelet count above a predetermined threshold platelet count during the period.
-
公开(公告)号:US11094406B2
公开(公告)日:2021-08-17
申请号:US14492618
申请日:2014-09-22
Applicant: GLAXOSMITHKLINE, LLC
Abstract: Methods and systems for transferring restricted distribution medical products to an over-the-counter general sales environment are provided. Methods and systems of dispensing non-prescription, behind-the-counter medical products from a vending machine in a general sales location are also provided. In some embodiments, methods and systems are provided for dispensing a medical product from a vending machine in a general sales location based, at least in part, on biometric data collected from the purchaser and, in some instances, based on self-selection and/or de-selection criteria, is provided. Further, methods and systems of switching prescription medical products to non-prescription, over-the-counter medical products are provided.
-
公开(公告)号:US10660898B2
公开(公告)日:2020-05-26
申请号:US16393210
申请日:2019-04-24
Applicant: GLAXOSMITHKLINE LLC
Inventor: Rosanna Tedesco , Junya Qu , Robert Sanchez , Ralph A. Rivero
IPC: A61K31/5377 , A61K31/337 , C07D235/10 , C07D235/24 , C07D403/04 , C07D405/04 , C07D413/04 , C07D417/04 , C07D235/08 , C07D401/10 , C07D403/10 , C07D405/10 , C07D409/10 , C07D413/10 , C07D417/10
Abstract: This invention relates to the use of benzimidazole derivatives for the modulation, notably the inhibition of the activity or function of the phosphoinositide 3′ OH kinase family (hereinafter PI3 kinases), suitably, PI3Kα, PI3Kδ, PI3Kβ, and/or PI3Kγ. Suitably, the present invention relates to the use of benzimidazoles in the treatment of one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries. More suitably, the present invention relates to PI3Kβ selective benzimidazoles compounds for treating cancer.
-
公开(公告)号:US10391717B2
公开(公告)日:2019-08-27
申请号:US15506819
申请日:2015-08-27
Applicant: GlaxoSmithKline LLC
Inventor: Jason R. Crosby , Gautam Debnath , Roger P. Fager , Peter R. Laubmeier , Curtis Emmanuel Stover
Abstract: Aspects of the present invention are directed to a heat sealed packaging wherein the heat seal is along a curved surface. Additional aspects of the present invention are directed to a device for heat sealing a package on a surface that is curved along the direction of force.
-
5.
公开(公告)号:US10286037B2
公开(公告)日:2019-05-14
申请号:US13984536
申请日:2012-02-09
Applicant: James Kranz , Joseph Rinella
Inventor: James Kranz , Joseph Rinella
Abstract: The invention is directed to a method for producing a polypeptide composition comprising: combining a polypeptide with a volatile additive to form a liquid mixture and lyophilizing the liquid mixture to obtain a lyophilized polypeptide composition.
-
公开(公告)号:US10172765B2
公开(公告)日:2019-01-08
申请号:US15102564
申请日:2014-12-11
Applicant: GlaxoSmithKline, LLC
Inventor: Amit Sabharwal , Sukhdev Singh Saini
Abstract: Aspects of the present invention are directed to a metered dose container. The container may comprise a body; a first barrier in contact with a base of the container and extending partially along the vertical axis of the body; a second barrier in contact with a top of the container and extending partially along with vertical axis of the body. The space between the first barrier and the second barrier preferably defines a loading chamber, the space between the second barrier and a front wall of the container preferably defines a dispensing chamber, and the space between a rear wall of the container and the first barrier preferably defines a storage chamber. The base preferably also comprises a depressible portion that can convert the container from a transit mode to a dispensing mode.
-
公开(公告)号:USD837056S1
公开(公告)日:2019-01-01
申请号:US29596007
申请日:2017-03-03
Applicant: GlaxoSmithKline LLC
Designer: Jamie Trafford Stone , Jonathan Norman Robert Hodges
-
公开(公告)号:US10064873B2
公开(公告)日:2018-09-04
申请号:US15464553
申请日:2017-03-21
Applicant: GlaxoSmithKline LLC
Inventor: Brian Alvin Johns
IPC: A61K31/56 , A61K31/568 , C07J63/00 , A61K31/225 , A61K31/472 , A61K31/495 , A61K31/505 , A61K31/5375 , A61K31/54 , A61K31/551 , A61K45/06 , C07D217/04 , C07D239/26 , C07D243/08 , C07D265/32 , C07C219/24 , C07C225/14 , A61K31/222 , A61K31/4985 , C07D239/48 , C07D498/14 , A61K31/397 , A61K31/40 , A61K31/44 , A61K31/506 , C07D205/04 , C07D207/09 , C07D213/40 , C07D265/30 , C07D413/06 , A61K31/58 , C07J53/00
Abstract: The present invention relates to compounds characterized by having a structure according to the following Formula I: or a pharmaceutically acceptable salt thereof. Compounds of the present invention are useful for the treatment or prevention of HIV.
-
公开(公告)号:USD826713S1
公开(公告)日:2018-08-28
申请号:US29596005
申请日:2017-03-03
Applicant: GlaxoSmithKline LLC
Designer: Jamie Trafford Stone , Jonathan Norman Robert Hodges
Abstract: The design consists of the features of configuration, shape, ornamentation and pattern of the COMBINED BOTTLE AND CAP shown in solid lines in the drawings. The portions in stippled lines do not form part of the design.FIG. 1 is a top perspective view of the combined bottle and cap;FIG. 2 is a bottom perspective view of the combined bottle and cap;FIG. 3 is a front elevational view of the combined bottle and cap;FIG. 4 is a rear elevational view of the combined bottle and cap;FIG. 5 is a side elevational view of the combined bottle and cap;FIG. 6 is a side elevational view of the combined bottle and cap rotated 180 degrees from FIG. 5;FIG. 7 is a top plan view of the combined bottle and cap; andFIG. 8 is a bottom plan view of the combined bottle and cap.Drawings of the design are included.
-
公开(公告)号:US09907847B2
公开(公告)日:2018-03-06
申请号:US15370211
申请日:2016-12-06
Applicant: GlaxoSmithKline LLC
Inventor: Diane Mary Coe , Stephen Allan Smith
IPC: A61K39/39 , A61K39/00 , C07D487/04
CPC classification number: A61K39/39 , A61K39/00 , A61K2039/55511 , C07D487/04
Abstract: Compounds of formula (I) and salts thereof: wherein R1 is n-C4-6alkyl or C1-2alkoxyC1-2alkyl-; R2 is hydrogen or methyl; each R3 is hydroxy, halo or n-C1-3alkyl; m is an integer having a value of 2 to 4; n is an integer having a value of 0 to 3; and p is an integer having a value of 0 to 2, are inducers of human interferon. Compounds which induce human interferon may be useful in the treatment of various disorders, for example the treatment of allergic diseases and other inflammatory conditions, for example allergic rhinitis and asthma, infectious diseases and cancer, and may also be useful as vaccine adjuvants.
-
-
-
-
-
-
-
-
-